MMP9 deficiency does not decrease blood-brain barrier disruption, but increases astrocyte MMP3 expression during viral encephalomyelitis

GLIA

Volumn 59, Issue 11, 2011, Pages 1770-1781

  Savarin, Carine ^a   Stohlman, Stephen A ^a   Rietsch, Anna M ^a   Butchi, Niranjan ^a   Ransohoff, Richard M ^a   Bergmann, Cornelia C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Astrocytes; Central nervous system (CNS); Coronavirus; Leukocytes; Matrix metalloproteinase (MMP)

Indexed keywords

GELATINASE B; STROMELYSIN;

ANIMAL CELL; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORONAVIRUS; ENCEPHALOMYELITIS; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL DEPLETION; VIRUS INFECTION;

ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; CELL SEPARATION; CORONAVIRUS INFECTIONS; ENCEPHALITIS, VIRAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS;

EID: 80052789825     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21222     Document Type: Article

References (47)

1. Agrawal S, Anderson P, Durbeej M, van Rooijen N, Ivars F, Opdenakker G, Sorokin LM. 2006. Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis. J Exp Med 203: 1007-1019.
2. Anthony DC, Miller KM, Fearn S, Townsend MJ, Opdenakker G, Wells GM, Clements JM, Chandler S, Gearing AJ, Perry VH. 1998. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J Neuroimmunol 87: 62-72.
3. Bechmann I, Galea I, Perry VH. 2007. What is the blood-brain barrier (not)? Trends Immunol 28: 5-11.
4. Bergmann CC, Lane TE, Stohlman SA. 2006. Coronavirus infection of the central nervous system: Host-virus stand-off. Nat Rev Microbiol 4: 121-132.
5. Bergmann CC, Marten NW, Hinton DR, Parra B, Stohlman SA. 2001. CD8 T cell mediated immunity to neurotropic MHV infection. Adv Exp Med Biol 494: 299-308.
6. Candelario-Jalil E, Yang Y, Rosenberg GA. 2009. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158: 983-994.
7. Crocker SJ, Milner R, Pham-Mitchell N, Campbell IL. 2006. Cell and agonist-specific regulation of genes for matrix metalloproteinases and their tissue inhibitors by primary glial cells. J Neurochem 98: 812-823.
8. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leuk Biol 83: 64-70.
9. DiStasi MR, Ley K. 2009. Opening the flood-gates: How neutrophil-endothelial interactions regulate permeability. Trends Immunology 30: 547-556.
10. Dubois B, Masure S, Hurtenbach U, Paemen L, Heremans H, van den Oord J, Sciot R, Meinhardt T, Hammerling G, Opdenakker G, et al. 1999. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest 104: 1507-1515.
11. Fleming JO, Trousdale MD, el-Zaatari FA, Stohlman SA, Weiner LP. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 58: 869-875.
12. Gottschall PE, Yu X. 1995. Cytokines regulate gelatinase A, B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem 64: 1513-1520.
13. Gurney KJ, Estrada EY, Rosenberg GA. 2006. Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol Dis 23: 87-96.
14. Hager M, Cowland JB, Borregaard N. 2010. Neutrophil granules in health and disease. J Intern Med 268: 25-34.
15. Hartung HP, Kieseier BC. 2000. The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system. J Neuroimmunol 107: 140-147.
16. Hosking MP, Liu L, Ransohoff RM, Lane TE. 2009. A protective role for ELR+ chemokines during acute viral encephalomyelitis. PLoS Pathog 5: e1000648.
17. Hosking MP, Tirotta E, Ransohoff RM, Lane TE. 2010. CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination. PLoS One 5: e11340.
18. Ireland DD, Stohlman SA, Hinton DR, Kapil P, Silverman RH, Atkinson RA, Bergmann CC. 2009. RNase L mediated protection from virus induced demyelination. PLoS Pathog 5: e1000602.
19. Kapil P, Atkinson R, Ramakrishna C, Cua DJ, Bergmann CC, Stohlman SA. 2009. Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control. J Virol 83: 5978-5986.
20. Kolaczkowska E, Grzybek W, van Rooijen N, Piccard H, Plytycz B, Arnold B, Opdenakker G. 2009. Neutrophil elastase activity compensates for a genetic lack of matrix metalloproteinase-9 (MMP-9) in leukocyte infiltration in a model of experimental peritonitis. J Leukoc Biol 85: 374-381.
21. Larsen PH, DaSilva AG, Conant K, Yong VW. 2006. Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice. J Neurosci 26: 2207-2214.
22. Liedtke W, Cannella B, Mazzaccaro RJ, Clements JM, Miller KM, Wucherpfennig KW, Gearing AJ, Raine CS. 1998. Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. Ann Neurol 44: 35-46.
23. Lin MT, Stohlman SA, Hinton DR. 1997. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J Virol 71: 383-391.
24. Mun-Bryce S, Rosenberg GA. 1998. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol 274 (5 Part 2): R1203-R1211.
25. Noble LJ, Donovan F, Igarashi T, Goussev S, Werb Z. 2002. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 22: 7526-7535.
26. Omari KM, John G, Lango R, Raine CS. 2006. Role for CXCR2 and CXCL1 on glia in multiple sclerosis. Glia 53: 24-31.
27. Omari KM, John GR, Sealfon SC, Raine CS. 2005. CXC chemokine receptors on human oligodendrocytes: Implications for multiple sclerosis. Brain 128 (Part 5): 1003-1015.
28. Opdenakker G, Nelissen I, Van Damme J. 2003. Functional roles and therapeutic targeting of gelatinase B, chemokines in multiple sclerosis. Lancet Neurol 2: 747-756.
29. Owens T, Bechmann I, Engelhardt B. 2008. Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol 67: 1113-1121.
30. Pagenstecher A, Stalder AK, Kincaid CL, Shapiro SD, Campbell IL. 1998. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol 152: 729-741.
31. Parks WC, Wilson CL, Lopez-Boado YS. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4: 617-629.
32. Paul R, Lorenzl S, Koedel U, Sporer B, Vogel U, Frosch M, Pfister HW. 1998. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 44: 592-600.
33. Phares TW, Marques CP, Stohlman SA, Hinton DR, Bergmann CC. 2010. Factors supporting intrathecal humoral responses following viral encephalomyelitis. J Virol 85: 2589-2598.
34. Rosell A, Lo EH. 2008. Multiphasic roles for matrix metalloproteinases after stroke. Curr Opin Pharmacol 8: 82-89.
35. Rosenberg GA. 2002. Matrix metalloproteinases in neuroinflammation. Glia 39: 279-291.
36. Savarin C, Bergmann CC, Hinton DR, Ransohoff RM, Stohlman SA. 2008. Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis. J Virol 82: 12432-12440.
37. Savarin C, Stohlman SA, Atkinson R, Ransohoff RM, Bergmann CC. 2010. Monocytes regulate T cell migration through the glia limitans during acute viral encephalitis. J Virol 84: 4878-4888.
38. Seals DF, Courtneidge SA. 2003. The ADAMs family of metalloproteases: Multidomain proteins with multiple functions. Genes Dev 17: 7-30.
39. Sixt M, Engelhardt B, Pausch F, Hallmann R, Wendler O, Sorokin LM. 2001. Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol 153: 933-946.
40. Sporer B, Paul R, Koedel U, Grimm R, Wick M, Goebel FD, Pfister HW. 1998. Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. J Infect Dis 178: 854-857.
41. Stohlman SA, Hinton DR, Parra B, Atkinson R, Bergmann CC. 2008. CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus. J Virol 82: 2130-2139.
42. Toft-Hansen H, Buist R, Sun XJ, Schellenberg A, Peeling J, Owens T. 2006. Metalloproteinases control brain inflammation induced by pertussis toxin in mice overexpressing the chemokine CCL2 in the central nervous system. J Immunol 177: 7242-7249.
43. Toft-Hansen H, Nuttall RK, Edwards DR, Owens T. 2004. Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis. J Immunol 173: 5209-5218.
44. Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T. 1998. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 161: 3767-3775.
45. Wang P, Dai J, Bai F, Kong KF, Wong SJ, Montgomery RR, Madri JA, Fikrig E. 2008. Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol 82: 8978-8985.
46. Zhou J, Marten NW, Bergmann CC, Macklin WB, Hinton DR, Stohlman SA. 2005. Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis. J Virol 79: 4764-4773.
47. Zhou J, Stohlman SA, Hinton DR, Marten NW. 2003. Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J Immunol 170: 3331-3336.